Columbia Care Inc. CCHW CCHW CCHWF 3LP released Monday preliminary results for the full year ended December 31, 2021, reporting revenue of $460 million, up by 156% from 2020.
At this time, the company is working to complete its first U.S. GAAP audit and will report its financial results for the fourth quarter and full-year ended December 31, 2021, before U.S. financial markets open on Thursday, March 24, 2022.
Full Year Preliminary Results Summary
- Revenue amounted to $460.08 million, compared to $179.50 million in 2020;
- Gross profit was $194.02 million, versus $62.14 million in the previous year;
- Net loss was $146.85 million, compared to a net loss of $119.65 million in 2020;
- Adjusted EBITDA was a gain of $57.85 million, versus adjusted EBITDA loss of $19.8 million in the prior year;
Columbia Care’s chief growth officer, Jesse Channon, will be one of the speakers at the Benzinga Cannabis Capital Conference in Miami. There’s still time to sign up for the event that will host many top names in the cannabis industry. Click here for more info.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.